Tazarotene Foam 0.1%
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Tazarotene Foam 0.1%, covering 2012-07-06 to 2020-05-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris [Phase 3]